as 06-06-2025 4:00pm EST
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Founded: | 2012 | Country: | United States |
Employees: | N/A | City: | LOS GATOS |
Market Cap: | 6.9M | IPO Year: | 2022 |
Target Price: | $11.67 | AVG Volume (30 days): | 257.0K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -6.78 | EPS Growth: | N/A |
52 Week Low/High: | $0.91 - $15.79 | Next Earning Date: | 05-13-2025 |
Revenue: | $3,284,000 | Revenue Growth: | 2.18% |
Revenue Growth (this year): | 46.26% | Revenue Growth (next year): | 58.02% |
TNON Breaking Stock News: Dive into TNON Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
24 days ago
GuruFocus.com
24 days ago
ACCESS Newswire
a month ago
MT Newswires
2 months ago
MT Newswires
2 months ago
ACCESS Newswire
2 months ago
MT Newswires
2 months ago
MT Newswires
2 months ago
The information presented on this page, "TNON Tenon Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.